Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | CES1 | P23141 | 6/20 | 0.33 |
| ▸ | CES2 | O00748 | 7/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL556316 | 0.98 | ALDH1A1 (0.40) | ALDH1A1CES1CES2LMNAHSD17B10 | |
| Acetic Acid SCHEMBL28104724 | 0.94 | ALDH1A1 (0.38) | ALDH1A1CES1HSD17B10TSHRAKR1B1 | |
| SCHEMBL11744217 | 0.92 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL557512 | 0.92 | ALDH1A1 (0.39) | ALDH1A1CES1CES2HSD17B10FAAH | |
| SCHEMBL556789 | 0.92 | ALDH1A1 (0.39) | ALDH1A1CES1CES2HSD17B10FAAH | |
| SCHEMBL133348 | 0.91 | ALDH1A1 (0.44) | ALDH1A1CES1CES2LMNAHSD17B10 | |
| Water SCHEMBL9118662 | 0.90 | ALDH1A1 (0.38) | ALDH1A1CES1CES2HSD17B10FAAH | |
| SCHEMBL1082002 | 0.90 | ALDH1A1 (0.38) | ALDH1A1CES1CES2HSD17B10FAAH | |
| SCHEMBL7889813 | 0.89 | ALDH1A1 (0.38) | ALDH1A1CES2TSHR | |
| SCHEMBL8561226 | 0.89 | ALDH1A1 (0.34) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 729 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12391717-B2 | Method for preparing sucrose-6-ester | ANHUI JINHE INDUSTRIAL CO., LTD. (CN) | 2025-08-19 | — | — | US | claimed |
| US-20230295210-A1 | METHOD FOR PREPARING SUCROSE-6-ESTER | ANHUI JINHE INDUSTRIAL CO., LTD. (CN) | 2023-09-21 | — | — | US | claimed |
| EP-4144744-A1 | METHOD FOR PREPARING SUCROSE-6-ESTER | Anhui Jinhe Industrial Co., Ltd. (CN) | 2023-03-08 | — | — | EP | claimed |
| WO-2022056913-A1 | PREPARATION METHOD FOR SUCROSE-6-CARBOXYLATE | 安徽金禾实业股份有限公司 | 2022-03-24 | — | — | WO | claimed |
| WO-2022051988-A1 | METHOD FOR PREPARING SUCROSE-6-ESTER | 安徽金禾实业股份有限公司 | 2022-03-17 | — | — | WO | claimed |
| US-11142542-B2 | Method for synthesizing sucrose-6-ester | ZHEJIANG NHU COMPANY LTD. (CN) | 2021-10-12 | — | — | US | claimed |
| EP-3858883-A1 | POLYMERIZABLE COMPOSITION FOR OPTICAL MEMBERS | Hoya Lens Thailand Ltd. (TH) | 2021-08-04 | — | — | EP | claimed |
| US-20210206903-A1 | POLYMERIZABLE COMPOSITION FOR OPTICAL MEMBERS | HOYA LENS THAILAND LTD. (TH) | 2021-07-08 | — | — | US | claimed |
| CN-112996798-A | Chlorination method of sucrose-6-carboxylate | 安徽金禾实业股份有限公司 | 2021-06-18 | — | — | CN | claimed |
| CN-112384522-A | Preparation method of sucrose-6-carboxylate | 安徽金禾实业股份有限公司 | 2021-02-19 | — | — | CN | claimed |
| EP-0530811-B1 | 5-Substituted 2-oxazolidinones | NIPPON PAINT CO LTD (JP) | 1997-06-25 | — | — | EP | claimed |
| EP-0776903-A1 | Improved sucrose-6-ester process | McNEIL-PPC, INC. (US) | 1997-06-04 | — | — | EP | claimed |
| WO-1996040825-A1 | MODIFIED AMINO CROSSLINKING AGENTS | CYTEC TECHNOLOGY CORP. (US) | 1996-12-19 | — | — | WO | claimed |
| US-5470969-A | Catalyzed sucrose-6-ester process | MCNEIL-PPC, INC. (US) | 1995-11-28 | — | — | US | claimed |
| EP-0677515-A1 | Method for preparing 2-oxazolidinone derivatives | NIPPON PAINT CO., LTD. (JP) | 1995-10-18 | — | — | EP | claimed |
| EP-0475619-B1 | Catalyzed sucrose-6-ester process | MCNEIL PPC INC (US) | 1995-10-11 | — | — | EP | claimed |
| EP-0475619-A1 | Catalyzed sucrose-6-ester process | McNEIL-PPC, INC. (US) | 1992-03-18 | — | — | EP | claimed |
| US-4404352-A | ORGANOTIN COMPOUNDS AS CATALYST AND AMINES TO GIVE CURED COATINGS WITH PARTIALLY BLOCKED ISOCYANATES | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1983-09-13 | — | — | US | claimed |
| EP-0073835-A1 | PROCESS FOR PRODUCING POLYURETHANE POLYMER | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1983-03-16 | — | — | EP | claimed |
| US-4322519-A | USING AN ORGANOTIN COMPOUND CATALYST | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1982-03-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11142542-B2 | Method for synthesizing sucrose-6-ester | SNRK, G6PD, TREH | ALDH1A1 2209/4885CES1 2099/4885CES2 1643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.